BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

Novus Scientific Release: Use of TIGR(R) Matrix Surgical Mesh in Multi-Center Randomized Controlled TRAM Flap Study Passes 20 Patient Mark and Wins Praise from Participating Surgeons


5/23/2011 10:32:59 AM

SINGAPORE, May 23, 2011 /PRNewswire/ -- Singapore company Novus Scientific Pte. Ltd announced that the TRAM Flap study (Abdominal Wall Closure After Lipectomy, TRAM/DIEP Flap - Comparison of TIGR® (100% Resorbable) vs Polypropylene (Permanent) Mesh) has passed the 20 patient mark, representing approximately one quarter of the 86 patient study compliment.

This groundbreaking multi-center, randomized trial involves University of California San Diego (UCSD) in the U.S. as well as National University Hospital and Tan Tock Seng Hospital in Singapore. Surgeons from all three study sites will be in attendance at IPRAS 2011, Vancouver, Canada, May 22nd-27th, 2011. Novus Scientific will also be present at IPRAS as an exhibitor at booth 808.

"We are very optimistic about the early results using TIGR® Matrixin this TRAM Flap study. TIGR® Matrix may provide a good option to avoid long-term complications associated with permanent meshes and the high cost of using biological meshes."-James J. Chao, MD FACS, Study Investigator, Professor of Plastic Surgery and Orthopedic Surgery, University of California, San Diego (UCSD) Medical Centre, USA.

"We are proud to have reached this important milestone of the study and it was truly a great team effort by all study investigators in the 3 hospitals. Early results for TIGR® Matrixlook excellent."- Associate Professor Thiam Chye Lim, Principal Investigator & Head of Division of Plastic, Reconstructive and Aesthetic Surgery, National University Hospital, Singapore.

"We're very pleased to be part of this important study and with how TIGR® Matrixfeels and conforms to the donor site. So far, results are good and look very promising."- Dr. Marcus Wong, Study Investigator, Consultant and Section Head, Plastic, Reconstructive and Aesthetic Surgery, Tan Tock Seng Hospital, Singapore.

TIGR® Matrixis the World's 1st Long-Term Resorbable Synthetic Mesh. US FDA cleared TIGR® Matrix Surgical Mesh for use in reinforcement of soft tissues where weakness exists in February 2010.

About Novus Scientific

Novus Scientific (www.novusscientific.com) is an innovator in the development and commercialization of resorbable synthetic medical devices. Global HQ is in Singapore while European Headquarters and the core R&D function are in Uppsala, Sweden. The company's roots are Swedish as all the founders of Novus Scientific are previous owners / senior managers / members of the soft tissue-engineering project within Uppsala-based, Radi Medical Systems AB (now owned by St. Jude Medical Inc). The US Division, Novus Scientific, Inc. is headquartered near Boston, one of the world's foremost medical research cities. From this hub, Novus Scientific, Inc. will distribute TIGR® Matrix Surgical Mesh throughout the United States, Canada, and Latin America.

TIGR® is a trademark of Novus Scientific Pte. Ltd

CONTACT:

Mark Hawthorne: +44 7748 988705 - mark.hawthorne@novusscientific.com
James Archetto: +1-781-577-2599 - jim.archetto@novusscientific.com, both of Novus Scientific
www.novusscientific.com

SOURCE Novus Scientific Pte. Ltd


Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->